ProShare Advisors’s ATAI Life Sciences ATAI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-10,333
| Closed | -$13.7K | – | 2073 |
|
2024
Q2 | $13.7K | Sell |
10,333
-1,302
| -11% | -$1.73K | ﹤0.01% | 1824 |
|
2024
Q1 | $22.9K | Buy |
11,635
+1,028
| +10% | +$2.03K | ﹤0.01% | 1967 |
|
2023
Q4 | $15K | Sell |
10,607
-246
| -2% | -$347 | ﹤0.01% | 1933 |
|
2023
Q3 | $14K | Buy |
10,853
+111
| +1% | +$143 | ﹤0.01% | 1798 |
|
2023
Q2 | $18.5K | Sell |
10,742
-758
| -7% | -$1.3K | ﹤0.01% | 1838 |
|
2023
Q1 | $20.8K | Sell |
11,500
-2,219
| -16% | -$4.02K | ﹤0.01% | 1734 |
|
2022
Q4 | $36.5K | Buy |
13,719
+108
| +0.8% | +$287 | ﹤0.01% | 1766 |
|
2022
Q3 | $45K | Buy |
13,611
+1,094
| +9% | +$3.62K | ﹤0.01% | 1667 |
|
2022
Q2 | $46K | Sell |
12,517
-4,072
| -25% | -$15K | ﹤0.01% | 1707 |
|
2022
Q1 | $84K | Sell |
16,589
-5,984
| -27% | -$30.3K | ﹤0.01% | 2060 |
|
2021
Q4 | $172K | Buy |
+22,573
| New | +$172K | ﹤0.01% | 2084 |
|